Vmbook Online ordering

Sagent Pharmaceuticals Inc

Sagent Pharmaceuticals Inc is a public company based in the United States that is primarily engaged in the development, manufacturing, and marketing of pharmaceutical products. The company's portfolio includes a wide range of generic injectable drugs, which are used to treat various medical conditions in areas such as critical care, oncology, and neurology.

Sagent Pharmaceuticals Inc is listed on the NASDAQ stock exchange under the ticker symbol "SGNT." The company's headquarters are located in Schaumburg, Illinois, and it has manufacturing facilities in the United States and India.

As a publicly traded company, Sagent Pharmaceuticals Inc is required to file regular financial reports with the Securities and Exchange Commission (SEC), which provide detailed information about the company's financial performance, business operations, and other relevant data. This information is publicly available and can be accessed through the SEC's website or through financial databases such as Bloomberg or Thomson Reuters.

It is important to note that investing in the stock market always carries risks, and it is important to carefully consider these risks before making any investment decisions. It is recommended that investors conduct their own research and consult with a financial advisor before making any investment decisions related to Sagent Pharmaceuticals Inc or any other company.